SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-028077
Filing Date
2020-10-13
Accepted
2020-10-13 20:21:02
Documents
2
Period of Report
2020-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9301
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3654
  Complete submission text file 0000899243-20-028077.txt   14355
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Issuer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O MAGENTA THERAPEUTICS, INC. 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
Driscoll Cindy (Reporting) CIK: 0001741269 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38541 | Film No.: 201237811